Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Int J STD AIDS ; 34(9): 588-602, 2023 08.
Artigo em Inglês | MEDLINE | ID: mdl-37247427

RESUMO

This is the first British Association of Sexual Health and HIV (BASHH) national guideline for the management of sexually transmitted enteric infections (STEI). This guideline is primarily aimed for level 3 sexual health clinics; however, it may also be applicable to other settings such as primary care or other hospital departments where individuals with STEI may present. This guideline makes recommendations on testing, management, partner notification and public health control of STEI.


Assuntos
Infecções por HIV , Saúde Sexual , Infecções Sexualmente Transmissíveis , Humanos , HIV , Infecções Sexualmente Transmissíveis/diagnóstico , Infecções Sexualmente Transmissíveis/tratamento farmacológico , Infecções Sexualmente Transmissíveis/epidemiologia , Infecções por HIV/diagnóstico , Infecções por HIV/tratamento farmacológico , Infecções por HIV/epidemiologia , Instituições de Assistência Ambulatorial , Reino Unido
2.
Helicobacter ; 25 Suppl 1: e12735, 2020 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-32918354

RESUMO

New imaging techniques are still the topic of many evaluations for both the diagnosis of Helicobacter pylori gastritis and the detection of early gastric cancer. Concerning invasive tests, there were studies on the reuse of the rapid urease test material for other tests, and a novel fluorescent method to be used for histology but with limited sensitivity. Progress occurred essentially in the molecular methods area, especially next-generation sequencing which is applied to detect both H pylori and the mutations associated with antibiotic resistance. For non-invasive tests, a few studies have been published on the validity of breath collection bags, the shortening of the testing time, the performance of different analysers or the added value of citric acid in the protocol. The accuracy of serological immunochromatographic tests is also improving. Multiplex serology detecting antibodies to certain proteins allows confirmation of a current infection. Dried blood spots can be used to collect and store blood without a loss of accuracy. Finally, the serum antibody titer can be useful in predicting the risk of gastric cancer. Several stool antigen tests were evaluated with good results, and a novel test using immunomagnetic beads coated with monoclonal antibodies is potentially interesting. PCR detection in stools can also be effective but needs an efficient DNA extraction method. The use of easyMAG® (bioMérieux) combined with Amplidiag® H pylori + ClariR (Mobidiag) appears to be powerful.


Assuntos
Infecções por Helicobacter/diagnóstico , Helicobacter pylori/isolamento & purificação , Antígenos de Bactérias/análise , Biópsia/métodos , Testes Respiratórios/métodos , Fezes/microbiologia , Humanos , Ureia/análise
3.
Am J Trop Med Hyg ; 100(3): 617-621, 2019 03.
Artigo em Inglês | MEDLINE | ID: mdl-30693857

RESUMO

Cystic echinococcosis (CE) is a zoonosis caused by the larval stage of the tapeworm Echinococcus granulosus. In humans, the infection induces the formation of parasitic cysts mostly in the liver and lungs, but virtually any organ can be affected. CE of the bone is one of the rarest forms of the disease, yet it is also extremely debilitating for patients and hard to manage for clinicians. Unlike abdominal CE, there is currently no expert consensus on the management of bone CE. In this study, we conducted a survey of the clinical records of seven European referral centers for the management of patients with CE and retrieved data on the clinical management of 32 patients with a diagnosis of bone CE. Our survey confirmed that the patients endured chronic debilitating disease with a high rate of complications (84%). We also found that diagnostic approaches were highly heterogeneous. Surgery was extensively used to treat these patients, as well as albendazole, occasionally combined with praziquantel or nitaxozanide. Treatment was curative only for two patients, with one requiring amputation of the involved bone. Our survey highlights the need to conduct systematic studies on bone CE, both retrospectively and prospectively.


Assuntos
Doenças Ósseas/epidemiologia , Doenças Ósseas/parasitologia , Equinococose/epidemiologia , Equinococose/patologia , Adolescente , Adulto , Albendazol/uso terapêutico , Anti-Helmínticos/uso terapêutico , Doenças Ósseas/patologia , Doenças Ósseas/terapia , Criança , Europa (Continente)/epidemiologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Adulto Jovem
4.
J Infect ; 78(3): 208-214, 2019 03.
Artigo em Inglês | MEDLINE | ID: mdl-30528872

RESUMO

LISTERIOSIS: is a foodborne illness that can result in septicaemia, Central Nervous System (CNS) disease, foetal loss and death in high risk patients. OBJECTIVES: To analyse the demographic trends, clinical features and treatment of non-perinatal listeriosis cases over a ten year period and identify mortality-associated risk factors. METHODS: Reported laboratory-confirmed non-pregnancy associated cases of listeriosis between 2006 and 2015 in England were included and retrospectively analysed. Multivariate logistic regression analysis was performed to determine independent risk factors for mortality. RESULTS: 1357/1683 reported cases met the inclusion criteria. Overall all-cause mortality was 28.7%; however, mortality rates declined from 42.1% to 20.2%. Septicaemia was the most common presentation 69.5%, followed by CNS involvement 22.4%. CNS presentations were significantly associated with age < 50 years, and septicaemia with older age. Age > 80 years (OR 3.32 95% CI 1.92-5.74), solid-organ malignancy (OR 3.42 95% CI 2.29-5.11), cardiovascular disease (OR 3.30 95% CI 1.64-6.63), liver disease (OR 4.61 95% CI 2.47-8.61), immunosuppression (OR 2.12 95% CI 1.40-3.21) and septicaemia (OR 1.60 95% CI 1.17-2.20) were identified as independent mortality risk factors. CONCLUSIONS: High risk groups identified in this study should be the priority focus of future public health strategies aimed at reducing listeriosis incidence and mortality.


Assuntos
Doenças Transmitidas por Alimentos/mortalidade , Listeriose/mortalidade , Saúde Pública/métodos , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Antibacterianos/farmacologia , Inglaterra/epidemiologia , Feminino , Doenças Transmitidas por Alimentos/complicações , Doenças Transmitidas por Alimentos/microbiologia , Humanos , Incidência , Listeria monocytogenes/efeitos dos fármacos , Listeriose/complicações , Modelos Logísticos , Masculino , Testes de Sensibilidade Microbiana , Pessoa de Meia-Idade , Gravidez , Saúde Pública/estatística & dados numéricos , Estudos Retrospectivos , Fatores de Risco , Sepse/microbiologia , Sepse/mortalidade , Adulto Jovem
5.
Harm Reduct J ; 15(1): 36, 2018 07 11.
Artigo em Inglês | MEDLINE | ID: mdl-29996865

RESUMO

BACKGROUND: People who inject drugs (PWID) are at an increased risk of wound botulism, a potentially fatal acute paralytic illness. During the first 6 months of 2015, a large outbreak of wound botulism was confirmed among PWID in Scotland, which resulted in the largest outbreak in Europe to date. METHODS: A multidisciplinary Incident Management Team (IMT) was convened to conduct an outbreak investigation, which consisted of enhanced surveillance of cases in order to characterise risk factors and identify potential sources of infection. RESULTS: Between the 24th of December 2014 and the 30th of May 2015, a total of 40 cases were reported across six regions in Scotland. The majority of the cases were male, over 30 and residents in Glasgow. All epidemiological evidence suggested a contaminated batch of heroin or cutting agent as the source of the outbreak. There are significant challenges associated with managing an outbreak among PWID, given their vulnerability and complex addiction needs. Thus, a pragmatic harm reduction approach was adopted which focused on reducing the risk of infection for those who continued to inject and limited consequences for those who got infected. CONCLUSIONS: The management of this outbreak highlighted the importance and need for pragmatic harm reduction interventions which support the addiction needs of PWID during an outbreak of spore-forming bacteria. Given the scale of this outbreak, the experimental learning gained during this and similar outbreaks involving spore-forming bacteria in the UK was collated into national guidance to improve the management and investigation of future outbreaks among PWID.


Assuntos
Botulismo/prevenção & controle , Surtos de Doenças/prevenção & controle , Redução do Dano , Dependência de Heroína/epidemiologia , Infecção dos Ferimentos/prevenção & controle , Adulto , Analgésicos Opioides/química , Botulismo/epidemiologia , Surtos de Doenças/estatística & dados numéricos , Contaminação de Medicamentos , Feminino , Heroína/química , Humanos , Masculino , Pessoa de Meia-Idade , Fatores de Risco , Gestão de Riscos , Escócia/epidemiologia , Infecção dos Ferimentos/epidemiologia , Adulto Jovem
6.
IDCases ; 8: 45-46, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28367407

RESUMO

Listeria monocytogenes is a known cause of gastroenteritis. Invasive disease can follow bacteremia causing meningoencephalitis, endocarditis and spontaneous miscarriages in immunocompromised patients and pregnant women respectively. We present the first case in England of endogenous endophthalmitis caused by L. monocytogenes following acute gastroenteritis in an immunocompetent host. A 50-year-old South Asian female presented with acute painful unilateral visual loss occurring shortly after an episode of self-limiting gastroenteritis. On examination, the eye was very inflamed with a hypopyon uveitis. A vitreous biopsy confirmed growth of L.monocytogenes serotype 1/2a. Diagnostic delay commonly occurs in endogenous endophthalmitis and exacerbates an already poor visual prognosis. Listeria spp. must be considered in ocular inflammation following gastroenteritis. The intraocular inflammation subsided but surgical intervention was required to remove vitreous debris and improve visual acuity.

7.
J Assoc Physicians India ; 64(10): 20-23, 2016 10.
Artigo em Inglês | MEDLINE | ID: mdl-27766798

RESUMO

BACKGROUND: Medical thoracoscopy has received interest in recent past for diagnostic as well as therapeutic uses. In this study we describe our experience with diagnostic medical thoracoscopy in pleural effusions of undiagnosed etiology. OBJECTIVE: 1.To detect diagnostic yield of medical thoracoscopy in pleural effusions of unknown etiology. 2.To find complication rate in these patients. METHODOLOGY: In a retrospective analysis of thoracoscopic procedures performed between March 2011 and December 2014, diagnostic yield and complications of thoracoscopic pleural biopsy for achieving a diagnosis in undiagnosed pleural effusions were evaluated. STATICAL ANALYSIS: Statistical analysis of all 60 patients underwent thoracoscopy was done and findings expressed in terms of percentages. RESULTS: A total of 60 patients (40 males and 20 females; mean age 45 years) underwent diagnostic pleuroscopy. Tuberculosis was diagnosed in 28 patients, Malignancy was found in 26 patients, three patients had pyogenic infections(empyema) and it was non diagnostic in three patients. There were no major complications, minor complications were observed in 10 patients(17%). INTERPRETATIONS: The diagnostic yield of medical thoracoscopy in our study was 95%. Minor complications were noted in ten patients (17%). CONCLUSIONS: Medical thoracoscopy is a valuable tool in the diagnosis of undiagnosed exudative pleural effusion. It is a simple and safe method with high diagnostic yield and with low complication rates.


Assuntos
Derrame Pleural/etiologia , Derrame Pleural/patologia , Toracoscopia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos
8.
Interact Cardiovasc Thorac Surg ; 14(4): 390-4, 2012 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-22253203

RESUMO

A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was: Are antibiotic implants like gentamicin-collagen implants useful in preventing sternal wound infections (SWIs)? Altogether, more than 484 papers were found using the reported search; of these, 7 represented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. We conclude that most randomized controlled trials (RCTs) have been performed with gentamicin-collagen sponges for sternal closure. Two out of four RCTs showed a significant benefit of the implant in a reduction in superficial and deep SWIs in routine and emergency cardiac surgery. One RCT showed a significant reduction in superficial infections in 2005, a follow-up trial by the same group in 2009 showed a reduction in deep infections as well. Another group has shown a reduction in deep and superficial SWI with gentamicin implant, in an RCT on 800 patients, however have not published details of the complete trial. The third trial on 542 patients showed no benefit of the implant, but was not adequately powered. However, the most recent multicentre RCT conducted on 1052 patients showed no benefit of gentamicin-collagen sponges in elective surgery (coronary artery bypass grafting and/or valve surgery) in high-risk patients with diabetes, obesity or both. Concerns were raised that gentamicin sponges dipped in saline 1-2 s prior to application may have lost the gentamicin into the saline, thereby reducing their efficacy and that some surgeons may have been unfamiliar with wound closure with sponges. However, these were robustly refuted by the authors. One RCT showed that gentamicin sponges may cause increased sternal rebleeding if used in double layers. Coagulase-negative staphylococci were predominantly isolated from infected wounds in all the trials except the one from USA, where infections were polymicrobial. Gentamicin resistance among common pathogens causing SWIs can vary from 15 to 80%. Gentamicin-collagen is unlikely to reduce SWIs in high-risk patients and polymicrobial infections.


Assuntos
Antibacterianos/administração & dosagem , Procedimentos Cirúrgicos Cardíacos/efeitos adversos , Colágeno , Gentamicinas/administração & dosagem , Mediastinite/prevenção & controle , Esternotomia/efeitos adversos , Tampões de Gaze Cirúrgicos , Infecção da Ferida Cirúrgica/prevenção & controle , Técnicas de Fechamento de Ferimentos/instrumentação , Benchmarking , Colágeno/efeitos adversos , Implantes de Medicamento , Farmacorresistência Bacteriana , Medicina Baseada em Evidências , Humanos , Mediastinite/microbiologia , Medição de Risco , Fatores de Risco , Tampões de Gaze Cirúrgicos/efeitos adversos , Infecção da Ferida Cirúrgica/microbiologia , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA